In Huntington disease, mutations in huntingtin (which normally undergoes different PTMs, such as phosphorylation, SUMOylation, ubiquitination, acetylation, proteolytic cleavage, and palmitoylation) significantly alters PTMs leading to changes in the clinical phenotype (Ehrnhoefer et al., 2011). The gene discussed is HTT; the disease is Huntington disease.